Workflow
自主研发
icon
Search documents
阿斯麦CEO出主意:中国可忍不了,西方不如…
Xin Lang Cai Jing· 2025-12-12 13:12
【文/观察者网 阮佳琪】 富凯出主意称,西方可以通过拒绝向中国提供"最新和最好的产品",以维持中方对西方技术的依赖,同 时拖慢中国自主技术进步的速度。 据他透露,目前阿斯麦对华出口的设备,比最新的高数值孔径光刻技术整整落后了八代,技术水平相当 于该公司2013、2014年销往西方客户的产品,技术差距超过十年。 "但问题的关键在于,我们要把这种技术差距拉大到何种程度?是让中国落后5年、10年,还是15 年?"富凯继而担忧称,如果西方过度收紧限制,将中国逼至绝境,迫使中方别无选择、只能彻底摆脱 对西方技术的依赖,反而会倒逼中国决心自主研发替代产品。从长远来看,这将导致西方彻底失去这一 庞大市场。 在专访中,去年接任CEO一职的富凯重申其观点,即"应向中国适度输出技术以防其自主研发形成竞争 力"。他进一步宣称,在对华技术出口限制问题上,西方需要找到一个微妙的平衡点。 "中国绝不会接受在技术方面被'卡脖子'的处境,"他解释道,"如果你是一个拥有14亿人口的大国,就必 然要谋求技术进步,这是不争的事实。" 阿 斯麦首席执行官克里斯托夫·富凯(左)。彭博社视频截图 在先进芯片制造领域,最关键的设备当属将芯片图案打印到硅晶 ...
出生安徽,台湾旺宏电子吴敏求之“铁汉”传奇
Xin Lang Cai Jing· 2025-12-11 06:12
Core Insights - The article highlights the recognition of Wu Minqiu, chairman of Winbond Electronics, as the recipient of the 19th Pan Wen-yuan Award, a prestigious honor in Taiwan's technology industry, emphasizing his significant contributions to the semiconductor sector [1][13]. Group 1: Background and Early Life - Wu Minqiu was born in 1948 in Anhui and moved to Taiwan as an infant, where he developed resilience in a challenging environment [3][16]. - His education at Cheng Kung University and Stanford University shaped his character, where he learned to survive in scarcity [3][16]. Group 2: Career Beginnings - In 1989, Wu made a bold decision to leave his high-paying job at Intel to establish Winbond Electronics with over 40 semiconductor experts, despite the nascent state of Taiwan's semiconductor industry [5][18]. - Initial funding challenges were overcome with the help of venture capitalist Hu Dinghua, who provided NT$800 million and connections to other financial institutions [5][18]. Group 3: Business Strategy and Challenges - Wu's strategy focused on independent research and development in the non-volatile memory sector, which was initially overlooked but later proved to be a wise decision as demand surged in the consumer electronics era [7][20]. - Winbond faced significant losses from 2012 to 2017, totaling NT$23 billion, yet Wu maintained his commitment to R&D and avoided layoffs during this period [9][20]. Group 4: Recovery and Growth - The company's turnaround was marked by a focus on technology, leading to partnerships with major clients like Nintendo and Apple, and establishing Winbond as a leader in NOR Flash technology [9][22]. - Wu's leadership resulted in a remarkable recovery from annual losses to stable profitability within five years, showcasing the importance of core technology independence [9][22]. Group 5: Recognition and Legacy - Wu's receipt of the Pan Wen-yuan Award is seen as a recognition of both his personal achievements and Winbond's innovative business model, reflecting a shift in Taiwan's semiconductor industry from technology importation to self-innovation [11][24]. - His story serves as an inspiration, illustrating the journey of Taiwan's semiconductor industry and the value of perseverance and innovation in overcoming adversity [12][25].
造就超大规模电力系统“超级大脑”
Ke Ji Ri Bao· 2025-12-10 00:11
Core Insights - China's monthly electricity consumption has surpassed 1 trillion kilowatt-hours for the first time, showcasing the strength of the southern regional electricity market in ensuring optimal supply during peak demand [1] - The "Tianquan" solver, developed independently, has significantly improved computational efficiency, outperforming imported solvers by 14% [1][9] Group 1: Development of "Tianquan" - The southern regional electricity market was among the first to undergo market-oriented reforms, transitioning from government pricing to a model based on electricity costs and environmental expenditures [2] - Initially, domestic solvers lagged significantly behind international counterparts, requiring 30 to 40 times longer to solve the same problems [2] - The development team recognized the risks of relying on foreign solvers, as they did not disclose operational formulas or models, leading to potential safety hazards [2] Group 2: Research and Optimization - The team conducted extensive research and discussions with experts to create optimized underlying code, which was identified as a key factor in improving performance [3][6] - The initial testing of "Tianquan" revealed a significant performance gap, taking 20,000 seconds for a case compared to 11 times faster for imported solvers [4] - The team faced challenges in accessing the operational processes of imported solvers, which were treated as "black boxes," complicating efforts to enhance "Tianquan" [4][6] Group 3: Testing and Implementation - After numerous simulations and optimizations, "Tianquan" achieved a breakthrough, matching and then exceeding the speed of imported solvers by 14% [7] - The reliability of "Tianquan" is critical for grid safety, leading to extensive testing with real data from power plants and substations [8] - Following two years of dual operation with imported solvers, "Tianquan" transitioned to independent operation, expanding its support from two-day trading to continuous monthly settlements [9] Group 4: Future Prospects - The successful development and application of "Tianquan" are seen as a significant contribution to energy security, aligning with national goals to maintain control over energy resources [9] - The southern regional electricity market aims to provide robust support for the national unified electricity market and extend solutions to other key industries such as oil and gas, aviation, and manufacturing [9]
儒竞科技:公司对行业动态保持密切关注
Zheng Quan Ri Bao Wang· 2025-12-09 13:40
Core Viewpoint - Rujing Technology (301525) emphasizes its commitment to closely monitor industry dynamics and leverage its technological advantages to strengthen its competitive foundation [1] Group 1 - The company will focus on self-research and development to solidify its competitive edge [1] - Rujing Technology is actively looking for targets and fields that are closely related to its existing industrial chain layout and business or technology [1] - The company aims to enhance its core competitiveness in its main business through these efforts [1] Group 2 - The company will comply with relevant laws and regulations regarding information disclosure if there are any related plans [1]
瑞德智能:公司采取“战略投资”与“自主研发”相结合的策略持续推进布局
Zheng Quan Ri Bao Wang· 2025-12-04 11:42
Core Viewpoint - The company is advancing its strategy by combining "strategic investment" and "independent research and development" to enhance its market position in the robotics industry [1] Strategic Investments - The company is focusing on strategic investments in key components of the industry chain, such as the zero-difference cloud-controlled robotic joint modules and the complete application of power plant inspection robots through Shenzhen Yutuo Intelligent [1] Product Development - The company has launched the AI Smart Bed 2.0 in collaboration with Tencent Cloud and is providing an integrated self-developed algorithm core controller for the "Mobile Love Home Desktop Robot" [1] Future Plans - The company will continue to dynamically optimize its cooperation strategies in line with technological trends and business needs, aiming to upgrade its intelligent product ecosystem, with significant developments to be disclosed in a timely manner as per regulations [1]
贵州百灵实控人被证监会立案;健友股份丙泊酚乳状注射液获FDA批准
Mei Ri Jing Ji Xin Wen· 2025-12-03 23:21
Group 1 - Guizhou BaiLing's actual controller Jiang Wei has been investigated by the China Securities Regulatory Commission (CSRC) for insider trading and information disclosure violations [1] - The investigation highlights the regulatory focus on key individuals and may increase operational uncertainty for Guizhou BaiLing, which has faced performance pressures in recent years [1] - The CSRC's actions reflect ongoing efforts to enhance the rule of law in the capital market [1] Group 2 - Jianyou Co., Ltd. has received ANDA approval from the FDA for its Propofol emulsion injection, marking a significant step in the company's internationalization of its formulations [2] - The product is expected to have a broad market potential in the U.S. as a commonly used sedative for surgeries, potentially driving revenue growth for the company [2] Group 3 - Shenzhen Xinlitai has been granted clinical trial approval for its innovative small molecule drug SAL0140, aimed at treating chronic kidney disease (CKD) [3] - SAL0140 is a proprietary aldosterone synthase inhibitor with potential applications in multiple significant chronic disease areas, indicating substantial market potential [3] - Successful development could open new growth avenues for Shenzhen Xinlitai [3] Group 4 - Junshi Biosciences reported a decrease in the shareholding percentage of Greenland Financial Investment Group and its affiliates from 5.0051% to 4.7129% due to share lending [4] - This change is a technical operation rather than an active reduction in holdings, but it brings the shareholding below the 5% disclosure threshold, warranting market attention on future actions [4] Group 5 - Sichuan Sichuang Medical Technology Co., Ltd. announced the resignation of Chairman Xu Yiran to facilitate governance structure optimization, while he will remain a board member [5] - The appointment of Wei Naixu as the new chairman indicates a strategic move to clarify responsibilities and strengthen governance rather than a response to a crisis [5]
贵州百灵实控人被证监会立案;健友股份丙泊酚乳状注射液获FDA批准|医药早参
Mei Ri Jing Ji Xin Wen· 2025-12-03 23:12
Group 1 - Guizhou BaiLing's actual controller Jiang Wei has been investigated by the China Securities Regulatory Commission (CSRC) for insider trading and information disclosure violations, indicating a focus on regulatory enforcement against key individuals [1] - The investigation may exacerbate operational uncertainties for Guizhou BaiLing, which has faced performance pressures in recent years, raising concerns about corporate governance and information disclosure risks [1] Group 2 - Jianyou Co., Ltd. has received ANDA approval from the FDA for its propofol emulsion injection, marking a significant step in the company's internationalization of its formulations [2] - The product, commonly used for sedation during surgeries, has substantial market potential in the U.S., which is expected to contribute to revenue growth for Jianyou [2] Group 3 - Shenzhen Xinlitai Pharmaceutical Co., Ltd. has been granted clinical trial approval for its innovative small molecule drug SAL0140, aimed at treating chronic kidney disease (CKD) [3] - SAL0140, an aldosterone synthase inhibitor, targets multiple significant chronic disease areas, including uncontrolled hypertension and CKD, presenting considerable market potential for the company [3] Group 4 - Junshi Biosciences reported a decrease in the shareholding percentage of Greenland Financial Investment Group and its affiliates from 5.0051% to 4.7129% due to share lending, falling below the 5% disclosure threshold [4] - This change is primarily a technical operation rather than an active reduction in holdings, but the market will need to monitor the future actions of these shareholders [4] Group 5 - Sichuang Medical Technology has elected Wei Naixu as the new chairman following the resignation of Xu Yiran, who stepped down to facilitate governance structure optimization [5] - Xu Yiran will remain on the board, indicating that the adjustment aims to clarify responsibilities and strengthen governance rather than signaling a crisis [5]
稀世珍宝再现我国,多国想用先进技术来换,都被我国逐一拒绝
Sou Hu Cai Jing· 2025-12-01 04:49
Core Insights - China has discovered a rare strategic resource, which has attracted immediate interest from the US and several European countries seeking to exchange advanced technology for this critical material [1][7] - The resource, rhenium, is essential for modern aviation and has a global annual production of less than 100 tons [1][3] - China has decided not to engage in resource-for-technology exchanges, emphasizing the importance of self-reliance and technological independence [10][21] Resource Discovery and Historical Context - Historically, China relied on imports for rhenium until significant discoveries were made in the 2010s [3][5] - In 2010, a major breakthrough occurred in Shaanxi, where a rhenium reserve of 176 tons was found, significantly enhancing China's position in the global rhenium market [5][7] - A subsequent discovery in 2017 in Anhui added another 30 tons of rhenium, further solidifying China's resource base [5][7] International Reactions and Strategic Decisions - Following the confirmation of over 200 tons of high-grade rhenium, Western industrial powers reacted strongly, attempting to negotiate technology exchanges [7][9] - Experts noted that many of the technologies offered were already developed in China, and the West's strict export controls on core technologies raised concerns about long-term dependency [9][10] - China's refusal to trade rhenium for technology is seen as a lesson learned from past experiences with rare earth exports, where the country did not gain significant technological advancements [10][19] Technological Advancements and Self-Reliance - China has made significant strides in developing its own rhenium processing capabilities, including the successful production of high-purity rhenium powder [16][17] - The establishment of a complete rhenium industry chain has allowed China to move beyond being a raw material supplier to producing high-value-added products [16][17] - The successful development of single-crystal turbine blades in 2015 marked a significant milestone in China's aerospace component manufacturing [14][19] Future Prospects and Applications - Rhenium's applications extend beyond aviation, including uses in rocket nozzles, superconductors, and as catalysts in various industries [17][19] - China aims to establish a national resource security baseline and actively participate in global industry standards, reflecting its transition from an importer to a technology innovation hub [19][21] - The journey of rhenium development in China illustrates the importance of mastering core technologies to maintain a competitive edge in a changing global landscape [21]
英威腾:公司预制式电力模块产品核心部件如UPS等均自主研发生产,具备自主知识产权
Mei Ri Jing Ji Xin Wen· 2025-11-28 01:29
Core Viewpoint - The company confirmed that its prefabricated power module products, including key components like UPS, are independently developed and produced, possessing full intellectual property rights [1] Group 1 - The company responded to an investor inquiry regarding the ownership of intellectual property for its prefabricated power module products [1] - Key components such as transformers, incoming/mother line cabinets, SVG cabinets, UPS output cabinets, maintenance bypass, and feeder cabinets are all developed in-house [1] - The company emphasizes its capability in independent research and production of core components [1]
2025华鹏变压器新产品鉴定会在京举行
Jing Ji Wang· 2025-11-27 08:10
Core Viewpoint - The 2025 Huapeng Transformer New Product Appraisal Conference showcased nine new products that achieved significant technological breakthroughs, filling domestic and international gaps in the transformer industry [1][2]. Group 1: Product Development and Innovation - Huapeng released nine new products, including the SF-245000/765 three-phase air-cooled generator step-up transformer and the SSZ18-510000/525-NX3 three-phase three-winding offshore platform step-up transformer, which represent leading technology levels in ultra-high voltage transformers [2]. - The new products address critical challenges in the transformer industry and have become the first domestic models to be exported, breaking foreign brands' technological monopolies [2][3]. - The company emphasizes the importance of independent research and development to break foreign monopolies and has increased R&D investment in various sectors, including power grids and offshore wind platforms [2]. Group 2: Market Performance and Collaboration - Huapeng's domestic orders reached 4.86 billion RMB and foreign orders totaled 3.75 billion RMB from January to October, with an overall output value of 7.85 billion RMB, reflecting an 8% year-on-year growth [3]. - The company has established collaborations with institutions such as the China Electric Power Research Institute and Southeast University, enhancing its innovation through deep integration of industry, academia, and research [3]. - The interest from multiple enterprises in Huapeng's new products indicates a strong market demand and potential for future partnerships [3].